Trial
NCT03996486
Study to Test the Safety of an Investigational Drug Given Repeatedly to Adult Men With Severe Hemophilia
Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Bayer
Collaborators
—
Condition
Hemophilia
Intervention
BAY1093884
Why stopped
Company decision
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-10-22